Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4 + T cells: Robust activation and proliferation with weak effector function during recall

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 787-797

  Wüthrich, Marcel ^a   Ersland, Karen ^a   Pick Jacobs, John C ^a   Gern, Benjamin H ^a   Frye, Christopher A ^a   Sullivan, Thomas D ^a   Brennan, Meghan B ^a   Filutowicz, Hanna I ^a   O'brien, Kevin ^a   Korthauer, Keegan D ^a   Schultz Cherry, Stacey ^a   Klein, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; EPITOPE; FUNGUS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2; L SELECTIN; RED FLUORESCENT PROTEIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLASTOMYCES DERMATITIDIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; KINETICS; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, FUNGAL; ANTIGENS, THY-1; BLASTOMYCES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; LUNG; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL;

EID: 84857175290     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05326-11     Document Type: Article

References (45)

1. Badovinac VP, Haring JS, Harty JT. 2007. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 26:827-841.
2. Beijersbergen A, Dulk-Ras AD, Schilperoort RA, Hooykaas PJ. 1992. Conjugative transfer by the virulence system of Agrobacterium tumefaciens. Science 256:1324-1327.
3. Bernard P, Couturier M. 1992. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J. Mol. Biol. 226:735-745.
4. Blair DA, Lefrancois L. 2007. Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc. Natl. Acad. Sci. U. S. A. 104:15045-15050.
5. Brandhorst TT, Gauthier GM, Stein RA, Klein BS. 2005. Calcium binding by the essential virulence factor BAD-1 of Blastomyces dermatitidis. J. Biol. Chem. 280:42156-42163.
6. Brandhorst TT, Wüthrich M, Warner T, Klein B. 1999. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J. Exp. Med. 189:1207-1216.
7. Catron DM, Rusch LK, Hataye J, Itano AA, Jenkins MK. 2006. CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J. Exp. Med. 203:1045-1054.
8. Cutler JE, Deepe GS, Jr, Klein BS. 2007. Advances in combating fungal diseases: vaccines on the threshold. Nat. Rev. Microbiol. 5:13-28.
9. De Boer RJ, Homann D, Perelson AS. 2003. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol. 171:3928-3935.
10. den Dulk-Ras A, Hooykaas PJ. 1995. Electroporation of Agrobacterium tumefaciens. Methods Mol. Biol. 55:63-72.
11. Ertelt JM, et al. 2009. Selective priming and expansion of antigen-specific Foxp3-CD4+ T cells during Listeria monocytogenes infection. J. Immunol. 182:3032-3038.
12. Fabien N, Bergerot I, Maguer-Satta V, Orgiazzi J, Thivolet C. 1995. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J. Autoimmun. 8:323-334.
13. Firpo EJ, et al. 2002. Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells. Immunology 107:480-488.
14. Fisher LD, van Belle G. 1993. Biostatistics: a methodology for the health sciences, p 611-613. John Wiley & Sons, New York, NY.
15. Grubin CE, Kovats S, deRoos P, Rudensky AY. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity 7:197-208.
16. Harvey RP, Schmid ES, Carrington CC, Stevens DA. 1978. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am. Rev. Respir. Dis. 117:695-703.
17. Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK. 2006. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science 312:114-116.
18. Iezzi G, Karjalainen K, Lanzavecchia A. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8:89-95.
19. Itano AA, et al. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cellmediated immunity. Immunity 19:47-57.
20. Jelley-Gibbs DM, Lepak NM, Yen M, Swain SL. 2000. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigendependent and late cytokine-driven expansion and differentiation. J. Immunol. 165:5017-5026.
21. Kemp RA, Powell TJ, Dwyer DW, Dutton RW. 2004. Cutting edge: regulation ofCD8+T cell effector population size. J. Immunol. 173:2923-2927.
22. Lara-Tejero M, Pamer EG. 2004. T cell responses to Listeria monocytogenes. Curr. Opin. Microbiol. 7:45-50.
23. Lefebvre B, Formstecher P, Lefebvre P. 1995. Improvement of the gene splicing overlap (SOE) method. Biotechniques 19:186-188.
24. Marzo AL, et al. 2005. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6:793-799.
25. Matz MV, et al. 1999. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 17:969-973.
26. Moon JJ, et al. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4:565-581.
27. Moon JJ, et al. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213.
28. Nemecek JC, Wüthrich M, Klein BS. 2006. Global control of dimorphism and virulence in fungi. Science 312:583-588.
29. Rees W, et al. 1999. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 96:9781-9786.
30. Romani L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23.
31. Rudensky A, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA, Jr. 1991. On the complexity of self. Nature 353:660-662.
32. Shaner NC, et al. 2004. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 22:1567-1572.
33. Singh A, Wuthrich M, Klein B, Suresh M. 2007. Indirect regulation of CD4 T-cell responses by tumor necrosis factor receptors in an acute viral infection. J. Virol. 81:6502-6512.
34. Smith AL, Wikstrom ME, Fazekas de St Groth B. 2000. Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. Immunity 13:783-794.
35. Sullivan TD, Rooney PJ, Klein BS. 2002. Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot. Cell 1:895-905.
36. Willis RA, Kappler JW, Marrack PC. 2006. CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc. Natl. Acad. Sci. U. S. A. 103:12063-12068.
37. Wüthrich M, Ersland K, Galles KJ, Sullivan TD, Klein BS. Fungi subvert vaccine T-cell priming at the respiratory mucosa by inducing MMP2 and retarding CCL7-mediated influx of inflammatory monocytes. Immunity, in press.
38. Wüthrich M, Filutowicz HI, Klein BS. 2000. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance. J. Clin. Invest. 106:1381-1389.
39. Wüthrich M, Filutowicz HI, Warner T, Deepe GS, Jr, Klein BS. 2003. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197:1405-1416.
40. Wüthrich M, Filutowicz HI, Warner T, Klein BS. 2002. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J. Immunol. 169:6969-6976.
41. Wüthrich M, Fisette PL, Filutowicz HI, Klein BS. 2006. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. J. Immunol. 176:5538-5547.
42. Wüthrich M, et al. 2011. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J. Clin. Invest. 121:554-568.
43. Wüthrich M, et al. 2011. A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J. Immunol. 187:1421-1431.
44. Wüthrich M, Klein BS. 2000. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J. Infect. Dis. 181:1720-1728.
45. Wüthrich M, Warner T, Klein BS. 2005. IL-12 Is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J. Immunol. 175:5288-5297.